Translate...

Novavax coronavirus vaccine induces immune response in early study, shares jump

Novavax coronavirus vaccine induces immune response in early study, shares jump
Novavax coronavirus vaccine induces immune response in early study, shares jump The company said it could start a large pivotal Phase III trial as soon as late September, and on a conference call added that it could produce 1 billion to 2 billion doses of the vaccine in 2021.